Previous Article | Next Article ![]()
Infection and Immunity, July 2005, p. 4441-4444, Vol. 73, No. 7
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.7.4441-4444.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
D. Neil Wedlock,1
Geoffrey W. de Lisle,1
Michèle M. Cooke,1,
Ricardo E. Tascon,2
Jose C. Ferraz,2
Douglas B. Lowrie,2
H. Martin Vordermeier,3
R. Glyn Hewinson,3 and
Bryce M. Buddle1*
AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand,1 National Institute for Medical Research, Mill Hill, London, United Kingdom,2 Veterinary Laboratory Agency, Weybridge, Surrey, United Kingdom3
Received 20 December 2004/ Returned for modification 4 February 2005/ Accepted 11 February 2005
Priming neonatal calves at birth with a Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine and boosting with a DNA vaccine consisting of plasmids encoding mycobacterial antigens Hsp65, Hsp70, and Apa or the reverse prime-boost sequence induced similar levels of protection against experimental challenge with Mycobacterium bovis. When M. bovis was isolated from a thoracic lymph node following challenge, the two groups of calves given the prime-boost regimen had significantly lower numbers of M. bovis isolates than those vaccinated with BCG alone. These observations suggest that the exact sequence of administration of a prime-boost vaccination regimen in a neonatal animal model is not critical to the development of immunity.
Present address: HortResearch, Mt. Albert, 120 Mt. Albert Road, Private Bag 92 169, Auckland, New Zealand.
Present address: Institute of Veterinary Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»